Literature DB >> 16138888

Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease.

Francis Marchlinski1, Fermin Garcia, Amir Siadatan, William Sauer, Stuart Beldner, Erica Zado, Henry Hsia, David Lin, Joshua Cooper, Ralph Verdino, Edward Gerstenfeld, Sanjay Dixit, Andrea Russo, David Callans.   

Abstract

Recurrent ventricular tachycardia (VT) in the setting of coronary artery disease is frequently a life-threatening electrophysiologic emergency. Even in patients with an implantable defibrillator, recurrent VT is frequently accompanied by repeated and disabling shock therapy. Catheter ablative therapy offers the ability to provide immediate control of recurrent VT. Long-term elimination of VT should be anticipated in most patients. This article reviews the strategies, tools, techniques, and expected outcome for catheter ablation of stable and unstable ventricular arrhythmias in the setting ischemic heart disease.

Entities:  

Mesh：

Year:  2005        PMID： 16138888     DOI： 10.1111/j.1540-8167.2005.50210.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


  6 in total

1.  Ablation of ventricular tachycardia.

Authors:  F C Garcia; E Valles; S Dhruvakumar; F E Marchlinski
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  Electrophysiologic and histopathologic findings of the ablation sites for ventricular fibrillation in a patient with ischemic cardiomyopathy.

Authors:  Akihiko Nogami; Shoichi Kubota; Masamitsu Adachi; Osamu Igawa
Journal:  J Interv Card Electrophysiol       Date:  2008-10-07       Impact factor: 1.900

Review 4.  Endocardial and epicardial mapping and catheter ablation of post myocardial infarction ventricular tachycardia: A substrate modification approach.

Authors:  Mauricio Arruda; Tamer Fahmy; Luciana Armaganijan; Luigi Di Biase; Dimpi Patel; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2010-04-16       Impact factor: 1.900

5.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

6.  A case of a human ventricular fibrillation rotor localized to ablation sites for scar-mediated monomorphic ventricular tachycardia.

Authors:  Justin Hayase; Roderick Tung; Sanjiv M Narayan; David E Krummen
Journal:  Heart Rhythm       Date:  2013-08-01       Impact factor: 6.343
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.